临床医学研究与实践2024,Vol.9Issue(20) :190-193.DOI:10.19347/j.cnki.2096-1413.202420047

分化型甲状腺癌药物治疗现状研究

Study on the current situation of drug therapy for differentiated thyroid cancer

范晓瑞 徐文健 苗良壮 鲁稳 闫晨名 高强 韩勇
临床医学研究与实践2024,Vol.9Issue(20) :190-193.DOI:10.19347/j.cnki.2096-1413.202420047

分化型甲状腺癌药物治疗现状研究

Study on the current situation of drug therapy for differentiated thyroid cancer

范晓瑞 1徐文健 1苗良壮 1鲁稳 1闫晨名 1高强 1韩勇1
扫码查看

作者信息

  • 1. 滨州医学院附属医院,山东滨州,256603
  • 折叠

摘要

甲状腺癌(TC)是常见的内分泌肿瘤,目前针对该病治疗仍以手术为主.除常规手术治疗外,常见的TC药物治疗手段包括放射性碘治疗(RAIT)、分子靶向药物治疗、促甲状腺激素(TSH)抑制治疗、新辅助化疗以及中医治疗等.本文旨在综述分化型甲状腺癌(DTC)药物治疗的研究现状,以为其治疗思路提供借鉴.

Abstract

Thyroid cancer(TC)is a common endocrine tumor.At present,surgery is still the main treatment for this disease.In addition to conventional surgical treatment,common TC drug treatments include radioactive iodine therapy(RAIT),molecular targeted drug therapy,thyroid stimulating hormone(TSH)inhibition therapy,neoadjuvant chemotherapy,and traditional Chinese medicine treatment,etc.This article aims to review the research status of drug therapy for differentiated thyroid cancer(DTC),so as to provide reference for its treatment ideas.

关键词

分化型甲状腺癌/药物治疗/分子机制/副作用

Key words

differentiated thyroid cancer/drug treatment/molecular mechanism/side effect

引用本文复制引用

出版年

2024
临床医学研究与实践

临床医学研究与实践

ISSN:
参考文献量1
段落导航相关论文